Diagnosis and treatment of hepatic sarcoidosis

Current Treatment Options in Gastroenterology

Volumn 9, Issue 6, 2006, Pages 475-483

  Ayyala, Uma S ^b   Padilla, Maria L ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIMALARIAL AGENT; AUROTHIOGLUCOSE; AZATHIOPRINE; BARBITURIC ACID DERIVATIVE; CHLOROQUINE; CYCLOSPORIN; DIGOXIN; DILTIAZEM; FLUCONAZOLE; GLUCOCORTICOID; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; INFLIXIMAB; LIVE VACCINE; MERCAPTOPURINE; METHOTREXATE; METHYLDOPA; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENYTOIN; PREDNISONE; PROTON PUMP INHIBITOR; QUINIDINE; QUININE; RIFAMPICIN; THALIDOMIDE; UNINDEXED DRUG; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; ACNE; ADRENAL INSUFFICIENCY; AGRANULOCYTOSIS; ALOPECIA; ANAPHYLAXIS; ANEMIA; ANOREXIA; AVASCULAR NECROSIS; BLOOD DYSCRASIA; BONE MARROW SUPPRESSION; CANCER; CATARACT; CLINICAL PROTOCOL; CORTICOSTEROID INDUCED MYOPATHY; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIARRHEA; DIET THERAPY; DIPLOPIA; DISEASE COURSE; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRY SKIN; EUPHORIA; EYE DISEASE; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GLAUCOMA; GLUCOSE INTOLERANCE; GRANULOMA; HEADACHE; HEALING IMPAIRMENT; HEPATOMEGALY; HIRSUTISM; HUMAN; HYPERTENSION; HYPERURICEMIA; INFECTION; INJECTION SITE REACTION; INSOMNIA; INTERSTITIAL LUNG DISEASE; IRRITABILITY; KIDNEY FAILURE; LEUKOPENIA; LIFESTYLE; LIVER ATROPHY; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FAILURE; LIVER FIBROSIS; LIVER NECROSIS; LIVER SARCOIDOSIS; LIVER TOXICITY; LIVER TRANSPLANTATION; LUNG TOXICITY; LUPUS LIKE SYNDROME; LYMPHOMA; MEDICAL DECISION MAKING; MOON FACE; MYALGIA; MYOPATHY; NAUSEA; OSTEOPOROSIS; PANCREATITIS; PERIPHERAL NEUROPATHY; PHOTOSENSITIVITY; PIGMENT DISORDER; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; RETINOPATHY; REVIEW; SARCOIDOSIS; SEDATION; SIDE EFFECT; SKIN BRUISING; STRIA; SYMPTOM; THROMBOCYTOPENIA; VOMITING;

EID: 33751323467     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-006-0004-9     Document Type: Review

References (36)

1. Gaya DR, Thorburn D, Oien KA, et al.: Hepatic granulomas: a 10 year single centre experience. J Clin Pathol 2003, 56:850-853.
2. Matheus T, Munoz S: Granulomatous liver disease and cholestasis. Clin Liver Dis 2004, 8:229-246.
3. Mert A, Ozaras R, Bilir M, et al.: The etiology of hepatic granulomas. J Clin Gastroenterol 2001, 32:275-276.
4. Costabel U: Sarcoidosis: clinical update. Eur Respir J Suppl 2001, 32:56s-68s.
5. Gavilan F, Pereda T, Sousa JM, et al.: Hepatic cirrhosis with sarcoid granulomas. Differential diagnosis and liver transplantation: a case report. Transplant Proc 2003, 35:713-714.
6. Judson MA: Hepatic, splenic, and gastrointestinal involvement with sarcoidosis. Semin Respir Crit Care Med 2002, 23:529-541.
7. Baughman RP, Teirstein AS, Judson MA, et al.: Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001, 164:1885-1889.
8. Mueller S, Boehme MW, Hofmann WJ, Stremmel W: Extrapulmonary sarcoidosis primarily diagnosed in the liver. Scand J Gastroenterol 2000, 35:1003-1008.
9. Valla DC, Benhamou JP: Hepatic granulomas and hepatic sarcoidosis. Clin Liver Dis 2000, 4:269-285.
10. Blich M, Edoute Y: Clinical manifestations of sarcoid liver disease. J Gastroenterol Hepatol 2004, 19:732-737.
11. Jung G, Brill N, Poll LW, et al.: MRI of hepatic sarcoidosis: large confluent lesions mimicking malignancy. AJR Am J Roentgenol 2004, 183:171-173.
12. Kaplan MM, Gershwin ME: Primary biliary cirrhosis. N Engl J Med 2005, 353:1261-1273.
13. Stanca CM, Fiel MI, Allina J, et al.: Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin Liver Dis 2005, 25:3 64-370.
14. Ramos-Casals M, Mana J, Nardi N, et al.: Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. Medicine (Baltimore) 2005, 84:69-80.
15. Kennedy PT, Zakaria N, Modawi SB, et al.: Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol 2006, 18:721-726.
16. Alenezi B, Lamoureux E, Alpert L, Szilagyi A: Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis. Dig Dis Sci 2005, 50:196-200.
17. Lipson EJ, Fiel MI, Florman SS, Korenblat KM: Patient and graft outcomes following liver transplantation for sarcoidosis. Clin Transplant 2005, 19:487-491.
18. Sandhu BS, Sanyal SJ: Management of ascites in cirrhosis. Clin Liver Dis 2005, 9:715-732.
19. Adler RA, Funkhouser HL, Petkov VI, Berger MM: Glucocorticoid-induced osteoporosis in patients with sarcoidosis. Am J Med Sci 2003, 325:1-6.
20. Barnes PJ: Molecular mechanisms and cellular effects of glucocorticosteroids. Immunol Allergy Clin North Am 2005, 25:451-468.
21. Baughman RP, Lower EE: Therapy for extrapulmonary sarcoidosis. Semin Respir Crit Care Med 2002, 23:589-596.
22. Sharma OP: Pulmonary sarcoidosis: management. J Postgrad Med 2002, 48:135-141.
23. Vucinic VM: What is the future of methotrexate in sarcoidosis? A study and review. Curr Opin Pulm Med 2002, 8:470-476.
24. Baughman RP, Koehler A, Bejarano PA, et al.: Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch Intern Med 2003, 163:615-620.
25. Lateef O, Shakoor N, Balk RA: Methotrexate pulmonary toxicity. Expert Opin Drug Saf 2005, 4:723-730.
26. Kandiel A, Fraser AG, Korelitz BI, et al.: Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005, 54:1121-1125.
27. Shibolet O, Kalish Y, Wolf D, et al.: Exacerbation of pulmonary sarcoidosis after liver transplantation. J Clin Gastroenterol 2002, 35:356-358.
28. Cengiz C, Rodriguez-Davalos M, deBoccardo G, et al.: Recurrent hepatic sarcoidosis post-liver transplantation manifesting with severe hypercalcemia: a case report and review of the literature. Liver Transpl 2005, 11:1611-1614.
29. Doty JD, Mazur JE, Judson MA: Treatment of sarcoiclosis with infliximab. Chest 2005, 127:1064-1071.
30. Chung ES, Packer M, Lo KH, et al.: Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 2003, 107:3133-3140.
31. Baert F, Noman M, Venneire S, et al.: Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 2003, 348:601-608.
32. Farrell RJ, Alsahli M, Jeen YT, et al.: Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial. Gastroenterology 2003, 124:917-924.
33. British Thoracic Society Standards of Care Committee: BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 2005, 60:800-805.
34. Gardam MA, Keystone EC, Menzies R, et al.: Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 2003, 3:148-155.
35. Moller DR: Treatment of sarcoidosis - from a basic science point of view. J Intern Med 2003, 253:31-40.
36. Nguyen YT, Dupuy A, Cordoliani F, et al.: Treatment of cutaneous sarcoidosis with thalidomide. J Am Acad Dermatol 2004, 50:235-241.